000 01380 a2200337 4500
005 20250516211103.0
264 0 _c20151001
008 201510s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD006681.pub3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTestroote, Mark
245 0 0 _aLow molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_cApr 2014
300 _aCD006681 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
650 0 4 _aAdult
650 0 4 _aAnticoagulants
_xadverse effects
650 0 4 _aHemorrhage
_xchemically induced
650 0 4 _aHeparin, Low-Molecular-Weight
_xadverse effects
650 0 4 _aHumans
650 0 4 _aImmobilization
_xadverse effects
650 0 4 _aLeg Injuries
_xtherapy
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aVenous Thromboembolism
_xprevention & control
700 1 _aStigter, Willem A H
700 1 _aJanssen, Loes
700 1 _aJanzing, Heinrich M J
773 0 _tThe Cochrane database of systematic reviews
_gno. 4
_gp. CD006681
856 4 0 _uhttps://doi.org/10.1002/14651858.CD006681.pub3
_zAvailable from publisher's website
999 _c23773865
_d23773865